Search filters

List of works by Luca Faloppi

ANGPT2 and NOS3 Polymorphisms and Clinical Outcome in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib

scientific article published on 20 July 2019

Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients.

scientific article published on 27 April 2016

Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma.

scientific article published on 09 May 2016

Bone metastases in biliary cancers: A multicenter retrospective survey

scientific article published on 07 April 2018

Cancer stem cell gene profile as predictor of relapse in high risk stage II and stage III, radically resected colon cancer patients

scientific article

Cetuximab: still an option in the treatment of pancreatic cancer? ⬇️

scientific article published on May 1, 2013

Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinoma

scientific article published on 23 June 2018

Clinical evidence for three distinct gastric cancer subtypes: time for a new approach

scientific article

Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter

scientific article published on 08 January 2019

Early onset of hypertension and serum electrolyte changes as potential predictive factors of activity in advanced HCC patients treated with sorafenib: results from a retrospective analysis of the HCC-AVR group

scientific article published on 17 February 2016

Effects of metformin on clinical outcome in diabetic patients with advanced HCC receiving sorafenib

scientific article published on 29 October 2015

Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report.

scientific article

Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patients.

scientific article

Estimating Survival Probabilities of Advanced Gastric Cancer Patients in the Second-Line Setting: The Gastric Life Nomogram

article

Evolving strategies for the treatment of hepatocellular carcinoma: from clinical-guided to molecularly-tailored therapeutic options.

scientific article published on 25 August 2010

Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel?

scientific article published on 27 July 2015

Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib

scientific article published on 24 August 2016

Interplay Between SIRT-3, Metabolism and Its Tumor Suppressor Role in Hepatocellular Carcinoma

scientific article

Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New

scientific article

Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale.

scientific article

Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: a retrospective study

scientific article published on 13 February 2017

Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy.

scientific article published on 21 January 2016

Multicenter Prospective Study of Angiogenesis Polymorphism Validation in HCC Patients Treated with Sorafenib. An INNOVATE Study Protocol

scientific article published on 09 May 2018

Natural history of malignant bone disease in hepatocellular carcinoma: final results of a multicenter bone metastasis survey.

scientific article

Novel perspectives for the treatment of gastric cancer: from a global approach to a personalized strategy.

scientific article published in May 2010

Optimizing renal function and outcome of patients with cT2 renal cell carcinoma

scientific article published on 01 March 2019

Panitumumab for the treatment of metastatic colorectal cancer: a review.

scientific article published on 07 August 2015

Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients

scientific article published on 03 September 2011

Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab

scientific article

Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients ⬇️

scientific article published on February 7, 2012

Predictive factors for sunitinib treatment response in advanced renal cell carcinoma: are we really making steps forward?

scientific article published on 01 February 2015

Prognostic Value for Incidental Antihypertensive Therapy With β-Blockers in Metastatic Colorectal Cancer.

scientific article

Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: implications for clinical management

scientific article published on 17 August 2015

Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab

scientific article published on 7 May 2015

Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin ⬇️

scientific article published on 26 March 2019

Selected gastrointestinal cancer presentations from the American Society of Clinical Oncology annual meeting 2013 in review: it is not about the destination, it is about the journey

scientific article

Selected news from the 2014 Genitourinary Cancers Symposium: translating novel strategies into clinical practice.

scientific article published in November 2014

Sorafenib does not improve efficacy of chemotherapy in advanced pancreatic cancer: A GISCAD randomized phase II study

scientific article published on 02 November 2013

Targeted therapy for solid tumors and risk of hypertension: a meta-analysis of 68077 patients from 93 phase III studies

scientific article published on 19 December 2019

The "angiogenetic ladder", step-wise angiogenesis inhibition in metastatic colorectal cancer.

scientific article published on 20 June 2014

The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following?

scientific article published on 17 May 2016

The Role of Aspirin as Antitumoral Agent for Heavily Pretreated Patients With Metastatic Colorectal Cancer Receiving Capecitabine Monotherapy

scientific article published on 04 August 2016

The Tower of Babel of liver metastases from colorectal cancer: are we ready for one language?

scientific article published on 08 September 2012

The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy.

scientific article published on 11 April 2016

The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management

scientific article published on 20 February 2014

The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management

scientific article

The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment.

scientific article published on 19 May 2014

The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib.

scientific article published on 10 September 2015

Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis.

scientific article published on December 2015

Toward molecularly selected chemotherapy for advanced gastric cancer: state of the art and future perspectives.

scientific article published on 20 May 2009

Tracking the 2015 Gastrointestinal Cancers Symposium: bridging cancer biology to clinical gastrointestinal oncology

scientific article

Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients

scientific article

VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study

scientific article published on 20 February 2014

Validation of a Simple Scoring System to Predict Sorafenib Effectiveness in Patients with Hepatocellular Carcinoma.

scientific article published on 3 August 2017

[Treatment of pancreatic cancer. Actuality and perspective].

scientific article published in May 2015

eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: final results of the ePHAS study

scientific article published on 04 April 2016

Paulina is supported by:

About Paulina

Help